Citation: D. Hurst et al., A FACILITY FOR SIMULTANEOUS PARTICLE IMAGE VELOCIMETRY AND HIGH-RESOLUTION UNSTEADY PRESSURE MEASUREMENT, Aeronautical Journal, 102(1014), 1998, pp. 201-209
Citation: St. Singer et al., BLEEDING DISORDERS IN NOONAN-SYNDROME - 3 CASE-REPORTS AND REVIEW OF THE LITERATURE, Journal of pediatric hematology/oncology, 19(2), 1997, pp. 130-134
Authors:
HOOTS K
LUSHER JM
MANCOJOHNSON M
POWELL JS
RAGNI M
CONSTANT J
HURST D
Citation: K. Hoots et al., PHASE-I PHARMACOKINETIC CROSSOVER TRIAL OF RECOMBINANT FVIII AND A NEW SUCROSE-FORMULATED RECOMBINANT FVIII, Blood, 90(10), 1997, pp. 3184-3184
Authors:
POWELL JS
HARRISON J
ZIAJA C
FEASTER J
HURST D
Citation: Js. Powell et al., EVALUATION OF THE SAFETY AND EFFICACY OF A NEW PLASMA-DERIVED ANTIHEMOPHILIC-FACTOR-VIII CONCENTRATE WITH SOLVENT-DETERGENT TREATMENT AND AN 80-DEGREES-C FINAL CONTAINER HEAT STEP, Blood, 90(10), 1997, pp. 689-689
Authors:
PRESCOTT R
NAKAI H
SAENKO EL
SCHARRER I
NILSSON IM
HUMPHRIES JE
HURST D
BRAY G
SCANDELLA D
Citation: R. Prescott et al., THE INHIBITOR ANTIBODY-RESPONSE IS MORE COMPLEX IN HEMOPHILIA-A PATIENTS THAN IN MOST NONHEMOPHILIACS WITH FACTOR-VIII AUTOANTIBODIES, Blood, 89(10), 1997, pp. 3663-3671
Citation: D. Remley et al., A COMPARISON OF PARENT AND CHILD PERCEIVED SELF-EFFICACY TO CONSUME FRUITS AND VEGETABLES, The FASEB journal, 10(3), 1996, pp. 1462-1462
Authors:
WHITFIELD J
HURST D
BENNETT MJ
SHERWOOD WG
HOGG R
GONSOULIN W
Citation: J. Whitfield et al., FETAL POLYCYSTIC KIDNEY-DISEASE ASSOCIATED WITH GLUTARIC ACIDURIA TYPE-II - AN INBORN ERROR OF ENERGY-METABOLISM, American journal of perinatology, 13(3), 1996, pp. 131-134
Citation: D. Hurst, FUNDAMENTAL FEMINISM - CONTESTING THE CORE CONCEPTS OF FEMINIST THEORY - GRANT,J, Canadian journal of sociology, 21(1), 1996, pp. 110-112
Authors:
LUSHER JM
HILLMANWISEMAN C
SIMPSON P
HURST D
Citation: Jm. Lusher et al., PLASMA FVIII LEVELS MEASURED AFTER INFUSION OF RECOMBINANT-F-VIII (RFVIII) VARY SIGNIFICANTLY WITH DIFFERENT ASSAY-METHODS - (WILL THE REALFVIII LEVEL PLEASE STAND UP), Pediatric research, 39(4), 1996, pp. 934-934
Citation: J. Lusher et al., KOGENATE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 7 STUDY YEARS, Blood, 88(10), 1996, pp. 1755-1755
Citation: J. Lusher et al., RECOMBINANT-FVIII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 5 STUDY YEARS, Thrombosis and haemostasis, 73(6), 1995, pp. 1012-1012
Authors:
INWOOD MI
LUSHER JM
ROUSELL RH
ABILDGAARD CF
ARKINS S
HILGARTNER MW
ZIMMERMANN R
HURST D
Citation: Mi. Inwood et al., INDUCTION OF IMMUNE TOLERANCE WITH KOGENATE(TM) RECOMBINANT FACTOR-VIII (RFVIII) IN HEMOPHILIA PATIENTS WITH HIGH-TITER INHIBITORS - AN UPDATE REPORT, Thrombosis and haemostasis, 73(6), 1995, pp. 1014-1014
Citation: J. Lusher et al., HUMAN RECOMBINANT DNA-DERIVED FVIII IN THE TREATMENT OF HEMOPHILIA-A - CONCLUSIONS AFTER 5 YEARS, Transfusion, 35(5), 1995, pp. 442-442
Citation: Jm. Lusher et al., RECOMBINANT FVIII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY AND INHIBITORDEVELOPMENT AFTER 5 STUDY YEARS, Pediatric research, 37(4), 1995, pp. 161-161
Authors:
VICHINSKY EP
HABERKERN CH
NEUMAYR L
EARLES AN
BLACK D
KOSHY M
PEGELOW C
ABBOUD M
OHENEFREMPONG K
IYER RV
NAGEL R
JOHNSON R
SEARS D
WONG M
PARKE J
BRAY G
HURST D
KOBLENZ L
VICHINSKY E
DEALARCON P
GROSSI M
WALDRON P
WALTERS M
RUSSO C
MURPHY S
SMITH H
WOODS G
GUARINI L
HURLET A
PIOMELLI S
KINNEY T
PHILLIPS G
DAESCHNER C
HOLBROOK T
BUCHANAN I
ECKMAN J
CLASTER S
HUME H
OLIVERI N
BELLEVUE R
MANKAD V
WANG W
MILNER P
JACKSON S
BENJAMIN L
BESTAK M
RADEL E
BARUCHEL S
ESSENTINE D
BLEI F
EMBURY S
MENTZER W
GILLETTE P
MILLER S
RAO S
GROVER R
RAMIREZ G
WETHERS D
GLADER B
JENNINGS W
RUCKNAGEL D
KALINYAK K
LANE P
TALISCHY N
IYER R
STEINBERG M
COOPER H
ORRINGER E
MANKAD V
YANG Y
JOHNSON C
POWARS D
Citation: Ep. Vichinsky et al., A COMPARISON OF CONSERVATIVE AND AGGRESSIVE TRANSFUSION REGIMENS IN THE PERIOPERATIVE MANAGEMENT OF SICKLE-CELL DISEASE, The New England journal of medicine, 333(4), 1995, pp. 206-213
Authors:
LUSHER JM
HILLMANWISEMAN C
SIMPSON P
HURST D
Citation: Jm. Lusher et al., PLASMA FVIII LEVELS MEASURED AFTER INFUSION OF RECOMBINANT-F-VIII (RFVIII) VARY SIGNIFICANTLY WITH DIFFERENT ASSAY-METHODS - (WILL THE REALFVIII LEVEL PLEASE STAND UP), Blood, 86(10), 1995, pp. 755-755
Citation: Egd. Tuddenham et al., INITIAL STUDIES OF GENETIC-FACTORS DEVELOPMENT IN PREVIOUSLY INHIBITOR PATIENTS (PUPS) WITH HEMOPHILIA TREATED WITH RECOMBINANT FACTOR-VIII, Blood, 86(10), 1995, pp. 2429-2429
Authors:
ARKIN S
LUSHER J
ABILDGAARD C
BOGDANOFF D
HURST D
Citation: S. Arkin et al., PATTERN OF BLEEDING EPISODES IN YOUNG HEMOPHILIA-A PATIENTS - A NATURAL-HISTORY OF RECOMBINANT FACTOR-VIII (RFVIII) TREATMENT OF PREVIOUSLYUNTREATED PATIENTS (PUPS), Blood, 86(10), 1995, pp. 3444-3444
Authors:
WARRIER I
LUSHER J
ARKIN S
ABILDGAARD C
TENGBORN L
HUTHKUEHNE A
HURST D
Citation: I. Warrier et al., CD4 COUNTS IN HIV-NEGATIVE PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A RECEIVING RFVIII (KOGENATE), Transfusion, 34(8), 1994, pp. 732-733